| FTSE 100United Kingdom | $10,767 | +0.72% |
| DAXGermany | $25,411 | +0.91% |
| CAC 40France | $7847.32 | +0.83% |
| SMISwitzerland | $14,539 | +0.53% |
| AEXNetherlands | $1133.19 | +0.14% |
| IBEX 35Spain | $19,033 | +0.23% |
| FTSE MIBItaly | $49,187 | +1.29% |
| OMX NordicScandinavia | $3225.43 | +1.57% |
Positive colorectal cancer treatment data lifted biotech stocks on OMX Nordic.
October's better-than-expected business morale boosted trading in German shares.
Plans to merge asset management units increased buying interest in European equities.
| Gold | $4032.50 | +0.61% |
| Silver | $54.17 | +0.86% |
| WTI Crude | $102.91 | -0.35% |
| Brent Crude | $111.99 | -4.05% |
| Bitcoin | $80,125 | +0.13% |
| VIX | $18.58 | -4.47% |
| US 10Y Yield | $4.98 | -0.16% |
Free daily close email covering Europe and 3 other regions — Gold, Bitcoin & Oil included. No spam, cancel anytime.
Subscribe free →